The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Women’s fertility is a ‘black box’. This biotech company wants to help crack it open

| | April 1, 2019

Fertility is like most aspects of medicine — it’s rarely discussed until a problem arises. But as women wait longer to start families, sometimes those discussions come too late. Modern Fertility is one of a growing number of biotech companies that want to start the conversation sooner.

Their goal, the companies say, is to help women be better informed and more proactive about their health. “There is a lot of confusion when women are trying to conceive,” says Afton Vechery, co-founder and CEO of Modern Fertility. “It’s a black box, and they are looking for more data to understand what’s going on.”

The company offers an at-home testing kit for up to eight different hormones, including the three most important ones related to fertility: anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and estradiol. As an unmarried woman in my early thirties who would like to have kids someday, I was curious about my own numbers.

Related article:  Can artificial intelligence improve IVF success rates?

Femtech may have become a fast-growing industry because it’s a genuinely needed one. There has long been a dearth of knowledge and investment in women’s health, and while companies like Modern Fertility are capitalizing on that gap, they’re also filling it with data.

Read full, original post: This Company Wants to Help Women Hack Their Fertility

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend